ConcertAI, Bayer join forces to advance precision oncology
, 2025-04-23 17:46:00 Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI’s Translational360 and AI SaaS offerings. The offerings use AI and machine learning-acquired insights to speed up clinical development in precision oncology. The agreement aims to utilize ConcertAI’s Translational360 offering, an integrated research-level longitudinal clinical molecular…